Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DAWN – Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc
DAWN
$7.20
Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $737,510,400.00
EPSttm : -0.89
finviz dynamic chart for DAWN
Day One Biopharmaceuticals, Inc
$7.20
3.15%
$0.22

Float Short %

13.27

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

-0.02

EPS Last/This Y

-0.17

EPS This/Next Y

0.36

Price

7.2

Target Price

23.56

Analyst Recom

1.2

Performance Q

14.83

Relative Volume

1.06

Beta

-1.27

Ticker: DAWN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25DAWN7.240.060.003098
2025-07-28DAWN7.110.060.033123
2025-07-29DAWN6.980.060.003219
2025-07-30DAWN6.860.060.003180
2025-07-31DAWN6.70.070.003143
2025-08-01DAWN6.640.060.103176
2025-08-04DAWN6.740.070.003136
2025-08-05DAWN6.870.070.063128
2025-08-06DAWN5.820.072.023373
2025-08-07DAWN6.030.110.123521
2025-08-08DAWN6.140.110.003580
2025-08-11DAWN5.90.110.003675
2025-08-12DAWN6.140.110.003685
2025-08-13DAWN6.220.110.003709
2025-08-14DAWN6.260.111.253707
2025-08-15DAWN6.760.110.003716
2025-08-18DAWN6.80.190.002149
2025-08-19DAWN6.820.180.232299
2025-08-20DAWN6.820.170.002355
2025-08-21DAWN6.990.170.002298
2025-08-22DAWN7.20.170.102294
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25DAWN7.23-591.0- -1.35
2025-07-28DAWN7.19-586.1- -1.35
2025-07-29DAWN6.99-586.1- -1.35
2025-07-30DAWN6.87-586.1- -1.35
2025-07-31DAWN6.71-586.1- -1.35
2025-08-01DAWN6.65-586.1- -1.35
2025-08-04DAWN6.74-586.1- -1.35
2025-08-05DAWN6.88-586.1- -1.35
2025-08-06DAWN5.82-586.1- -1.35
2025-08-07DAWN6.03-586.1- -1.35
2025-08-08DAWN6.10-586.1- -1.18
2025-08-11DAWN5.90-180.0- -1.27
2025-08-12DAWN6.14-179.8- -1.27
2025-08-13DAWN6.21-179.8- -1.27
2025-08-14DAWN6.26-179.8- -1.27
2025-08-15DAWN6.76-179.8- -1.19
2025-08-18DAWN6.80-173.3- -1.19
2025-08-19DAWN6.82-173.3- -1.19
2025-08-20DAWN6.81-173.3- -1.19
2025-08-21DAWN6.99-173.3- -1.19
2025-08-22DAWN7.20-173.3- -1.19
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25DAWN-0.180.3813.77
2025-07-28DAWN-0.18-1.3713.77
2025-07-29DAWN-0.18-1.3713.77
2025-07-30DAWN-0.18-1.3713.77
2025-07-31DAWN-0.18-1.3713.77
2025-08-01DAWN-0.18-1.3713.77
2025-08-04DAWN-0.18-2.9313.77
2025-08-05DAWN-0.18-2.9313.77
2025-08-06DAWN-0.18-2.9313.77
2025-08-07DAWN-0.18-2.9313.77
2025-08-08DAWN-0.18-2.9313.62
2025-08-11DAWN-0.18-3.0213.62
2025-08-12DAWN-0.18-3.0213.13
2025-08-13DAWN-0.18-3.0213.13
2025-08-14DAWN-0.18-3.0213.13
2025-08-15DAWN-0.18-3.0213.13
2025-08-18DAWN-0.18-7.0113.27
2025-08-19DAWN-0.17-7.0113.27
2025-08-20DAWN-0.27-7.0113.27
2025-08-21DAWN-0.27-7.0113.27
2025-08-22DAWN-0.20-7.0113.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.29

Avg. EPS Est. Current Quarter

-0.28

Avg. EPS Est. Next Quarter

-0.31

Insider Transactions

-0.2

Institutional Transactions

-7.01

Beta

-1.27

Average Sales Estimate Current Quarter

38

Average Sales Estimate Next Quarter

41

Fair Value

Quality Score

42

Growth Score

29

Sentiment Score

88

Actual DrawDown %

74.9

Max Drawdown 5-Year %

Target Price

23.56

P/E

Forward P/E

PEG

P/S

3.93

P/B

1.6

P/Free Cash Flow

EPS

-0.91

Average EPS Est. Cur. Y​

-1.19

EPS Next Y. (Est.)

-0.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-50.63

Relative Volume

1.06

Return on Equity vs Sector %

-45.3

Return on Equity vs Industry %

-32.4

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.17

EBIT Estimation

Day One Biopharmaceuticals, Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 182
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading